Stay updated on TRACE Ⅱ Clinical Trial
Sign up to get notified when there's something new on the TRACE Ⅱ Clinical Trial page.

Latest updates to the TRACE Ⅱ Clinical Trial page
- CheckyesterdayChange DetectedThe page has undergone significant changes with the complete removal of two important clinical trial references related to ischemic stroke treatments, which may impact the credibility and comprehensiveness of the information provided.SummaryDifference0.4%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant revisions, including the removal of detailed descriptions of a clinical trial for Acute Ischemic Stroke and the update of the revision number from v2.14.4 to v2.15.0. Additionally, the name of the collaborator, Guangzhou Recomgen Biotech Co., Ltd., remains, but the context has changed.SummaryDifference10%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
Stay in the know with updates to TRACE Ⅱ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TRACE Ⅱ Clinical Trial page.